Loading company…
OneChain Immunotherapeutics develops biomedicines used to create immunotherapies for hematological malignancies.
Founded in 2020 and based in Barcelona, Spain, OneChain Immunotherapeutics SL makes biomedicines used to create immunotherapies for hematological malignancies. Its products target various tumors, including cortical T-cell acute lymphoblastic leukemia. The company is at the seed stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in